No results found Policy and EU affairs Web Team 13/10/2026 Policy and EU affairs Web Team 13/10/2026 Lung Cancer Europe sets out its position on the EU Biotech Act after Brussels expert dialogue Read More Policy and EU affairs Web Team 02/10/2026 Policy and EU affairs Web Team 02/10/2026 The EU Biotech Act: what it means for people living with lung cancer Read More Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026 What the EU Critical Medicines Act means for lung cancer Read More Policy and EU affairs, Access to treatment Web Team 30/04/2026 Policy and EU affairs, Access to treatment Web Team 30/04/2026 How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe Read More
Policy and EU affairs Web Team 13/10/2026 Policy and EU affairs Web Team 13/10/2026 Lung Cancer Europe sets out its position on the EU Biotech Act after Brussels expert dialogue Read More
Policy and EU affairs Web Team 02/10/2026 Policy and EU affairs Web Team 02/10/2026 The EU Biotech Act: what it means for people living with lung cancer Read More
Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026 What the EU Critical Medicines Act means for lung cancer Read More
Policy and EU affairs, Access to treatment Web Team 30/04/2026 Policy and EU affairs, Access to treatment Web Team 30/04/2026 How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe Read More